English

DNAPRINT GENOMICS INC

EDGAR

Filing (10QSB) · filed 2007-11-14

40 filing records in this dataset, filed from 2001-04-02 to 2007-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

701 thousand USD

2007-03-31 · USD

Exact inputs and evidence

Revenue: 701013 USD Source

Operating margin

-206.24%

2007-03-31 · %

Exact inputs and evidence

Operating Income: -1445802 USD Source
Revenue: 701013 USD Source

Cash and cash equivalents: 269 thousand USD 2007-03-31 Source
Exact value

269345 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-11-14.

Financial data available through: 2004-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2004-12-31
Operating income: 5 of 11 periods available· newest 2004-12-31
Net income: 6 of 11 periods available· newest 2004-12-31
Operating cash flow: 5 of 11 periods available· newest 2004-12-31
Capital expenditure: 5 of 11 periods available· newest 2004-12-31
assets: No compatible figures in this window
Total liabilities: 2 of 11 periods available· newest 2004-12-31
Current assets: 3 of 11 periods available· newest 2004-12-31
Current liabilities: 3 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+10.7%

Prior period

USD 709,638

2003-01-01 – 2003-12-31
Current period

USD 785,632

2004-01-01 – 2004-12-31

Exact inputs and evidence

785632 − 709638 = 75994 USD

709638 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
785632 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Year-over-year change in Revenue: 75994 USD Concept: fundies:Revenue Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 785632 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3183 Input fundies:Revenue: 709638 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3183
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.05 million

Prior period

−USD 3.73 million

2003-01-01 – 2003-12-31
Current period

−USD 7.79 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-7789905 − -3734982 = -4054923 USD

-3734982 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-7789905 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Year-over-year change in Net income: -4054923 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -7789905 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3969 Input fundies:NetIncome: -3734982 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3969
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.66 million

Prior period

−USD 3.76 million

2003-01-01 – 2003-12-31
Current period

−USD 1.11 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-1106857 − -3764425 = 2657568 USD

-3764425 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-1106857 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Year-over-year change in Operating cash flow: 2657568 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1106857 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990 Input fundies:OperatingCashFlow: -3764425 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-75.1%

Prior period

USD 56,969

2003-01-01 – 2003-12-31
Current period

USD 14,165

2004-01-01 – 2004-12-31

Exact inputs and evidence

14165 − 56969 = -42804 USD

56969 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
14165 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Year-over-year change in Capital expenditure: -42804 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 14165 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993 Input fundies:CapitalExpenditure: 56969 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 785,632 100% of revenue
Cost of revenue USD 507,927 65% of revenue
Operating expenses USD 3.61 million 460% of revenue
Operating income −USD 3.33 million −424% of revenue
Tax, interest and other Derived USD 4.46 million 567% of revenue
Net income −USD 7.79 million −992% of revenue

Cash

Operating cash flow −USD 1.11 million −141% of revenue
Capital expenditure USD 14,165 1.8% of revenue
Free cash flow Derived −USD 1.12 million −143% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 15,165% of revenue.
2000 Operating loss: operating costs were 1,730% of revenue.
2002 Operating loss: operating costs were 1,516% of revenue.
2003 Operating loss: operating costs were 979% of revenue.
2004 Operating loss: operating costs were 524% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	133187	20197790 Derived	-20064603	-3090 Derived	-20061513	Unavailable	Source 1999-01-01 – 1999-12-31: 133187 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -20064603 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -20061513 USD Inspect Net Income Open source
2000 2000-01-01 – 2000-12-31	33236	575025 Derived	-541789	-350000 Derived	-191789	-574910 Derived	Source 2000-01-01 – 2000-12-31: 33236 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -541789 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -191789 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 24460 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 599370 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	184551	2798158 Derived	-2613607	500017 Derived	-3113624	-1587829 Derived	Source 2002-01-01 – 2002-12-31: 184551 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -2613607 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -3113624 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -1571375 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 16454 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	709638	6944408 Derived	-6234770	-2499788 Derived	-3734982	-3821394 Derived	Source 2003-01-01 – 2003-12-31: 709638 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -6234770 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -3734982 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -3764425 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 56969 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	785632	4120050 Derived	-3334418	4455487 Derived	-7789905	-1121022 Derived	Source 2004-01-01 – 2004-12-31: 785632 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -3334418 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -7789905 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1106857 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 14165 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 785.6K 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	133187	Revenue: 133187 Open source
20002000-12-31	Revenue	33236	Revenue: 33236 Open source
20022002-12-31	Revenue	184551	Revenue: 184551 Open source
20032003-12-31	Revenue	709638	Revenue: 709638 Open source
20042004-12-31	Revenue	785632	Revenue: 785632 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

10.7% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 133187 Open source
20002000-12-31	Year over year	-75%	Revenue: 33236 Open source Revenue: 133187 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 184551 Open source
20032003-12-31	Year over year	284.5%	Revenue: 709638 Open source Revenue: 184551 Open source
20042004-12-31	Year over year	10.7%	Revenue: 785632 Open source Revenue: 709638 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -424.4% 2004

Net margin -991.5% 2004

Free cash flow margin -142.7% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-15,065%	Operating Income: -20064603 Open source Revenue: 133187 Open source
20002000-12-31	Operating margin	-1,630.1%	Operating Income: -541789 Open source Revenue: 33236 Open source
20022002-12-31	Operating margin	-1,416.2%	Operating Income: -2613607 Open source Revenue: 184551 Open source
20032003-12-31	Operating margin	-878.6%	Operating Income: -6234770 Open source Revenue: 709638 Open source
20042004-12-31	Operating margin	-424.4%	Operating Income: -3334418 Open source Revenue: 785632 Open source
19991999-12-31	Net margin	-15,062.7%	Net Income: -20061513 Open source Revenue: 133187 Open source
20002000-12-31	Net margin	-577.1%	Net Income: -191789 Open source Revenue: 33236 Open source
20022002-12-31	Net margin	-1,687.1%	Net Income: -3113624 Open source Revenue: 184551 Open source
20032003-12-31	Net margin	-526.3%	Net Income: -3734982 Open source Revenue: 709638 Open source
20042004-12-31	Net margin	-991.5%	Net Income: -7789905 Open source Revenue: 785632 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 133187 Open source
20002000-12-31	Free cash flow margin	-1,729.8%	Revenue: 33236 Open source Operating Cash Flow: 24460 Open source Capital Expenditure: 599370 Open source
20022002-12-31	Free cash flow margin	-860.4%	Revenue: 184551 Open source Operating Cash Flow: -1571375 Open source Capital Expenditure: 16454 Open source
20032003-12-31	Free cash flow margin	-538.5%	Revenue: 709638 Open source Operating Cash Flow: -3764425 Open source Capital Expenditure: 56969 Open source
20042004-12-31	Free cash flow margin	-142.7%	Revenue: 785632 Open source Operating Cash Flow: -1106857 Open source Capital Expenditure: 14165 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.1M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	Not reported	No source recorded
20002000-12-31	Operating cash flow	24460	Operating Cash Flow: 24460 Open source
20022002-12-31	Operating cash flow	-1571375	Operating Cash Flow: -1571375 Open source
20032003-12-31	Operating cash flow	-3764425	Operating Cash Flow: -3764425 Open source
20042004-12-31	Operating cash flow	-1106857	Operating Cash Flow: -1106857 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.1M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	Unavailable	No source recorded
20002000-12-31	Free cash flow	-574910	Operating Cash Flow: 24460 Open source Capital Expenditure: 599370 Open source
20022002-12-31	Free cash flow	-1587829	Operating Cash Flow: -1571375 Open source Capital Expenditure: 16454 Open source
20032003-12-31	Free cash flow	-3821394	Operating Cash Flow: -3764425 Open source Capital Expenditure: 56969 Open source
20042004-12-31	Free cash flow	-1121022	Operating Cash Flow: -1106857 Open source Capital Expenditure: 14165 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	No source recorded
2000-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
20032003-12-31	Liabilities / assets	Not reported	Total Liabilities: 3325656 Open source
20042004-12-31	Liabilities / assets	Not reported	Total Liabilities: 1695855 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.89× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Current assets / current liabilities	Not reported	No source recorded
2000-12-31	Current assets / current liabilities	Not reported	No source recorded
20022002-12-31	Current assets / current liabilities	0.02×	Current Assets: 35144 Open source Current Liabilities: 1527433 Open source
20032003-12-31	Current assets / current liabilities	0.39×	Current Assets: 1001256 Open source Current Liabilities: 2542178 Open source
20042004-12-31	Current assets / current liabilities	0.89×	Current Assets: 1406128 Open source Current Liabilities: 1571545 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 20.06 million Exact value Exact value: -20061513 USD 1999-01-01 – 1999-12-31: -20061513 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 1999-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -20061513 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20061513 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-01-000054.txt#1225 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 191,789 Exact value Exact value: -191789 USD 2000-01-01 – 2000-12-31: -191789 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 2000-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -191789 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -191789 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1589 The citation records this snapshot. The page link may show a newer release later.	USD 24,460 Exact value Exact value: 24460 USD 2000-01-01 – 2000-12-31: 24460 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DNAPRINT GENOMICS INC · 2000-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Operating Cash Flow: 24460 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24460 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1603 The citation records this snapshot. The page link may show a newer release later.	USD 599,370 Exact value Exact value: 599370 USD 2000-01-01 – 2000-12-31: 599370 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DNAPRINT GENOMICS INC · 2000-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Capital Expenditure: 599370 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 599370 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1606 The citation records this snapshot. The page link may show a newer release later.	−USD 574,910 Calculation and evidence 24460 − 599370 USD Exact free cash flow: -574910 USD 2000-01-01 – 2000-12-31: 24460 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 599370 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DNAPRINT GENOMICS INC · 2000-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Free cash flow: -574910 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24460 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1603 Input fundies:CapitalExpenditure: 599370 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1606 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 2.59 million Exact value Exact value: -2593906 USD 2001-01-01 – 2001-12-31: -2593906 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 2001-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -2593906 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2593906 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1589 The citation records this snapshot. The page link may show a newer release later.	−USD 1.57 million Exact value Exact value: -1565452 USD 2001-01-01 – 2001-12-31: -1565452 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DNAPRINT GENOMICS INC · 2001-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Operating Cash Flow: -1565452 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1565452 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1603 The citation records this snapshot. The page link may show a newer release later.	USD 145,540 Exact value Exact value: 145540 USD 2001-01-01 – 2001-12-31: 145540 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DNAPRINT GENOMICS INC · 2001-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Capital Expenditure: 145540 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 145540 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1606 The citation records this snapshot. The page link may show a newer release later.	−USD 1.71 million Calculation and evidence -1565452 − 145540 USD Exact free cash flow: -1710992 USD 2001-01-01 – 2001-12-31: -1565452 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 145540 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DNAPRINT GENOMICS INC · 2001-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Free cash flow: -1710992 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1565452 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1603 Input fundies:CapitalExpenditure: 145540 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001070876-02-000030.txt#1606 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 3.11 million Exact value Exact value: -3113624 USD 2002-01-01 – 2002-12-31: -3113624 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 2002-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -3113624 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3113624 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-014810.txt#3128 The citation records this snapshot. The page link may show a newer release later.	−USD 1.57 million Exact value Exact value: -1571375 USD 2002-01-01 – 2002-12-31: -1571375 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DNAPRINT GENOMICS INC · 2002-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Operating Cash Flow: -1571375 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1571375 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-014810.txt#3160 The citation records this snapshot. The page link may show a newer release later.	USD 16,454 Exact value Exact value: 16454 USD 2002-01-01 – 2002-12-31: 16454 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DNAPRINT GENOMICS INC · 2002-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Capital Expenditure: 16454 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16454 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-014810.txt#3164 The citation records this snapshot. The page link may show a newer release later.	−USD 1.59 million Calculation and evidence -1571375 − 16454 USD Exact free cash flow: -1587829 USD 2002-01-01 – 2002-12-31: -1571375 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 16454 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DNAPRINT GENOMICS INC · 2002-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Free cash flow: -1587829 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1571375 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-014810.txt#3160 Input fundies:CapitalExpenditure: 16454 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-014810.txt#3164 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 3.73 million Exact value Exact value: -3734982 USD 2003-01-01 – 2003-12-31: -3734982 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 2003-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -3734982 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3734982 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3969 The citation records this snapshot. The page link may show a newer release later.	−USD 3.76 million Exact value Exact value: -3764425 USD 2003-01-01 – 2003-12-31: -3764425 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DNAPRINT GENOMICS INC · 2003-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Operating Cash Flow: -3764425 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3764425 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990 The citation records this snapshot. The page link may show a newer release later.	USD 56,969 Exact value Exact value: 56969 USD 2003-01-01 – 2003-12-31: 56969 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DNAPRINT GENOMICS INC · 2003-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Capital Expenditure: 56969 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 56969 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993 The citation records this snapshot. The page link may show a newer release later.	−USD 3.82 million Calculation and evidence -3764425 − 56969 USD Exact free cash flow: -3821394 USD 2003-01-01 – 2003-12-31: -3764425 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 56969 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DNAPRINT GENOMICS INC · 2003-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Free cash flow: -3821394 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3764425 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990 Input fundies:CapitalExpenditure: 56969 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 7.79 million Exact value Exact value: -7789905 USD 2004-01-01 – 2004-12-31: -7789905 USD Inspect Net Income Open source Share or cite Citation for Net Income · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Net Income: -7789905 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7789905 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3969 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Exact value Exact value: -1106857 USD 2004-01-01 – 2004-12-31: -1106857 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Operating Cash Flow: -1106857 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1106857 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990 The citation records this snapshot. The page link may show a newer release later.	USD 14,165 Exact value Exact value: 14165 USD 2004-01-01 – 2004-12-31: 14165 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Capital Expenditure: 14165 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14165 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993 The citation records this snapshot. The page link may show a newer release later.	−USD 1.12 million Calculation and evidence -1106857 − 14165 USD Exact free cash flow: -1121022 USD 2004-01-01 – 2004-12-31: -1106857 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 14165 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DNAPRINT GENOMICS INC · 2004-12-31 DNAPRINT GENOMICS INC (edgar:1127354) Free cash flow: -1121022 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:56:05Z Snapshot: 71150e9eb7a695930af060642d9f783c5eb3854d592bc124a21e976cc770e818 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1127354?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1106857 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3990 Input fundies:CapitalExpenditure: 14165 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1127354/0001144204-05-016153.txt#3993 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

40 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001127354, 1127354, edgar:1127354

DNAPRINT GENOMICS INC

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation